Does anti-TNF therapy influence the performance of mycobacterium tuberculosis antigen-specific interferon-gamma assays? A French multicenter experience

Inflammatory Bowel Diseases

Volumn 17, Issue 8, 2011, Pages 1824-

  Del Tedesco, E ^a   Roblin, X ^a   Laharie, D ^b   Peyrin Biroulet, L ^c  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^b HAUT LÉVÊQUE HOSPITAL   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; MYCOBACTERIUM ANTIGEN; TUMOR NECROSIS FACTOR INHIBITOR;

CD4+ T LYMPHOCYTE; ENTERITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERFERON GAMMA RELEASE ASSAY; LETTER; MEMORY T LYMPHOCYTE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; TUBERCULIN TEST;

FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; LATENT TUBERCULOSIS; MALE; MASS SCREENING; MYCOBACTERIUM TUBERCULOSIS; TUBERCULIN TEST; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79960281919     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21602     Document Type: Letter

References (4)

1. Qumseya BJ, Ananthakrishnan AN, Skaros S, et al. QuantiFERON TB gold testing for tuberculosis screening in an inflammatory bowel disease cohort in the United States. Inflamm Bowel Dis. 2010 [Epub ahead of print].
2. Del Tedesco E, Roblin X, Laharie D, et al. Interferon gamma release assay (IGRA) and/or tuberculin skin test (TST) in inflammatory bowel disease population: discordance and performance. Best strategy for detecting tuberculosis. Gastroenterology. 2010; 138 (suppl 1): W1200.
3. Matulis G, Juni P, Villiger PM, et al. Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases performance of a Mycobacterium tuberculosis antigen specific IFN-gamma assay. Ann Rheum Dis. 2008; 67: 84-90.
4. Hamdi H, Mariette X, Godot V, et al. Inhibition of antituberculosis T-lymphocyte function with tumour necrosis factor antagonists. Arthritis Res Ther. 2006; 8: R114.